The Court of the European Union confirms the condemnation of a pharmaceutical company for abuse of dominant position but reduces the fine imposed (AstraZeneca)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On 1 July 2010, the General Court of the European Union upheld the conviction of the AstraZeneca group for abuse of a dominant position. In 2005, the Commission had found two abusive practices: the group's misleading statements to various national patent offices had allowed it to unduly extend the